Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Voyageur Pharmaceuticals Ltd
(OP:
VYYRF
)
0.0500
UNCHANGED
Last Price
Updated: 3:46 PM EDT, Oct 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
September 28, 2023
--News Direct--
Via
News Direct
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
September 28, 2023
Proactive Research Analyst Daniel Appiah speaks to Thomas Warner from the Londons studio after publishing a new research note on Canadian medical imaging contrast media company Voyageur Pharmaceuticals...
Via
TheNewswire.com
Voyageur Pharmaceuticals with a "big market to go for"
June 07, 2023
Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in...
Via
TheNewswire.com
Voyageur Pharmaceuticals with a "big market to go for"
June 07, 2023
Voyageur Pharmaceuticals with a "big market to go for"
Via
News Direct
Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs
May 24, 2023
Via
TheNewswire.com
Voyageur Pharmaceuticals Ltd. Announces Update To PEA and a Related New Opportunity To Market High Purity USP Barium Sulfate
August 19, 2021
Calgary, Alberta - TheNewswire - August 19, 2021 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") has been working with SGS Canada Inc. on the Preliminary Economic...
Via
TheNewswire.com
Voyageur Pharmaceuticals Announces Board of Director Changes and 2nd quarter Financial Results
July 26, 2021
Calgary, Alberta - TheNewswire - July 26th, 2021 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”). Voyageur is very pleased to announce that Frank Wright and Ralph...
Via
TheNewswire.com
Voyageur Pharmaceuticals Ltd. Announces Completion of Private Placement
June 14, 2021
Calgary, Alberta - TheNewswire - June 14, 2021 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") announces that, further to news releases dated April 13 and 23, and...
Via
TheNewswire.com
Exposures
Product Safety
Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement
May 28, 2021
Calgary, Alberta – TheNewswire - May 28, 2021 – Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC:VYYRF) (the "Company" or "Voyageur") announces that, further to news releases dated April 13 and 23, 2021...
Via
TheNewswire.com
Voyageur Pharmaceuticals Ltd. Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
May 17, 2021
Via
Get News
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
May 17, 2021
Calgary, Alberta - TheNewswire - May 17, 2021 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada...
Via
TheNewswire.com
Exposures
Product Safety
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast
May 05, 2021
Calgary, Alberta - TheNewswire - May 5, 2021 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has received approval from Health Canada...
Via
TheNewswire.com
Exposures
Product Safety
Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product
May 04, 2021
Via
Get News
Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out
April 20, 2021
Calgary, Alberta – TheNewswire - April 20, 2021 – Voyageur Pharmaceuticals Ltd. (TSX.V:VM) USA (OTC:VYYRF) (the “Company” or “Voyageur”), is pleased to announce that the D.C. Circuit Court of Appeals
Via
TheNewswire.com
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.